Talin1 dysfunction is genetically linked to systemic capillary leak syndrome.

Area of Science:

• Genetics
• Molecular Biology
• Vascular Biology

Background:

• Systemic capillary leak syndrome (SCLS) is a rare, life-threatening condition characterized by severe vascular leakage.
• The exact cause and triggers of SCLS remain unknown, and effective treatments are lacking.

Purpose of the Study:

• To investigate the genetic basis of familial Systemic Capillary Leak Syndrome (SCLS).
• To elucidate the molecular mechanisms underlying SCLS pathogenesis.
• To identify potential therapeutic targets for SCLS.

Main Methods:

• Genetic analysis of a familial SCLS case to identify causative variants.
• Functional studies using endothelial cells (ECs) with a specific TLN1 gene variant.
• Cellular assays to assess endothelial barrier function and cell adhesion.

Main Results:

• A heterozygous splice-site variant in the TLN1 gene was identified in a familial SCLS case, suggesting autosomal dominant inheritance.
• The identified TLN1 variant disrupts endothelial barrier integrity and adherens junction organization in vitro.
• Mechanistically, the variant sequesters vinculin, destabilizing endothelial cell-extracellular matrix adhesions.

Conclusions:

• Pathogenic variants in the TLN1 gene are proposed as a cause of SCLS.
• The findings reveal a molecular mechanism involving talin1 dysfunction and endothelial barrier failure.
• This research opens avenues for developing targeted therapies for SCLS.